Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Leukaemia lineage specification caused by cell-specific Mll-Enl translocations

Oncogene volume 27, pages 1945–1950 (2008)Cite this article

Abstract

Chromosomal translocations involving the Mixed-Lineage Leukaemia (MLL) gene underlie many human leukaemias and MLL rearrangements are found in both acute myelogenous and acute lymphoblastic leukaemias. To assess the functionally relevant haematopoietic cell contexts for MLL fusions to be tumorigenic, we have generated different lines of mice in which de novo Mll-associated translocations occur. In these models, reciprocal chromosomal translocations occur by means of Cre-loxP-mediated recombination (translocator mice) in different cells of the haematopoietic system (namely haematopoietic stem cells, semi-committed progenitors or committed T or B cells). Translocations between Mll and Enl cause myeloid neoplasias, initiating in stem cells or progenitors while no tumours arose when the translocation was restricted to the B-cell compartment. Despite the absence of tumorigenesis, Mll-Enl translocations did occur and Mll-Enl fusion mRNA was expressed in B-cell-restricted translocators. A permissive cellular environment is therefore required for oncogenicity of Mll-associated translocations since the occurrence of Mll-Enl does not promote unrestricted proliferation in all haematopoietic cellular contexts, consistent with a specific instructive role of the MLL-fusion proteins in leukaemogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Ayton PM, Cleary ML . (2003). Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev 17: 2298–2307.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bloomfield CD, Archer KJ, Mrozek K, Lillington DM, Kaneko Y, Head DR et al. (2002). 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 33: 362–378.

    Article  PubMed  Google Scholar 

  • Collins EC, Pannell R, Simpson EM, Forster A, Rabbitts TH . (2000). Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development. EMBO Rep 1: 127–132.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA et al. (1996). An Mll-Af9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 85: 853–861.

    Article  CAS  PubMed  Google Scholar 

  • Cozzio A, Passegue E, Ayton PM, Karsunky H, Cleary ML, Weissman IL . (2003). Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 17: 3029–3035.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Daser A, Rabbitts TH . (2004). Extending the repertoire of the mixed lineage leukemia gene MLL in leukemogenesis. Genes Dev 18: 965–974.

    Article  CAS  PubMed  Google Scholar 

  • Drynan LF, Pannell R, Forster A, Chan NMM, Cano F, Daser A et al. (2005). Mll fusions generated by Cre-lox P-mediated de novo translocations can induce lineage reassignment in tumorigenesis. EMBO J 24: 3136–3146.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Felix CA . (2001). Leukemias related to treatment with DNA topoisomerase II inhibitors. Med Pediatr Oncol 36: 525–535.

    Article  CAS  PubMed  Google Scholar 

  • Forster A, Pannell R, Drynan LF, McCormack M, Collins EC, Daser A et al. (2003). Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer. Cancer Cell 3: 449–458.

    Article  CAS  PubMed  Google Scholar 

  • Huret JL, Dessen P, Bernheim A . (2001). An atlas of chromosomes in hematological malignancies. Example: 11q23 and MLL. Leukaemia 15: 987–999.

    Article  CAS  Google Scholar 

  • Kogan SC, Ward JM, Anver MR, Berman JJ, Brayton C, Cardiff RD et al. (2002). Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 100: 238–245.

    Article  CAS  PubMed  Google Scholar 

  • McCormack MP, Forster A, Drynan LF, Pannell R, Rabbitts TH . (2003). The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development. Mol Cell Biol 23: 9003–9013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Metzler M, Forster A, Pannell R, Arends MJ, Daser A, Lobato MN et al. (2006). A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology. Oncogene 25: 3093–3103.

    Article  CAS  PubMed  Google Scholar 

  • Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, Allis CD et al. (2002). MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell 10: 1107–1117.

    Article  CAS  PubMed  Google Scholar 

  • Milne TA, Martin ME, Brock HW, Slany RK, Hess JL . (2005). Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications. Cancer Res 65: 11367–11374.

    Article  CAS  PubMed  Google Scholar 

  • Pui CH, Campana D . (2007). Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia. Leukemia 21: 593–594.

    Article  CAS  PubMed  Google Scholar 

  • Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W et al. (2002a). Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 359: 1909–1915.

    Article  PubMed  Google Scholar 

  • Pui CH, Relling MV, Campana D, Evans WE . (2002b). Childhood acute lymphoblastic leukemia. Rev Clin Exp Hematol 6: 161–180; discussion 200–202.

    Article  CAS  PubMed  Google Scholar 

  • Rabbitts TH . (1991). Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 67: 641–644.

    Article  CAS  PubMed  Google Scholar 

  • Rickert RC, Roes J, Rajewsky K . (1997). B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res 25: 1317–1318.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM et al. (2001). Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1: 4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was funded by the Medical Research Council. FC was supported by the César Milstein Memorial studentship of the Darwin Trust, Edinburgh. We thank Mark Bowen for his help with the histology sample preparations and Angela Middleton and Gareth King for assistance with the animal welfare.

Author information

Author notes

  1. F Cano

    Present address: 3Current address: Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2XY, UK.,

Authors and Affiliations

  1. MRC Laboratory of Molecular Biology, Cambridge, UK

    F Cano, L F Drynan, R Pannell & T H Rabbitts

  2. Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, UK

    T H Rabbitts

Authors
  1. F Cano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L F Drynan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Pannell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T H Rabbitts
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T H Rabbitts.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cano, F., Drynan, L., Pannell, R. et al. Leukaemia lineage specification caused by cell-specific Mll-Enl translocations. Oncogene 27, 1945–1950 (2008). https://doi.org/10.1038/sj.onc.1210818

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210818

Keywords

This article is cited by

Search

Advanced search

Quick links